Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan S Bielack

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Frontiers in Oncology|September 26, 2022
Systemic treatment for primary malignant sarcomas arising in craniofacial bonesStefan S Bielack
European Journal of Cancer (Oxford, England : 1990)|April 14, 2010
Osteosarcoma: time to move on?Stefan S Bielack
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Surgical expertise and outcome in osteosarcoma trialsStefan S Bielack, Heribert Jürgens
Journal of the National Cancer Institute|April 29, 2010
Re: Late recurrence in pediatric cancer: a report from the childhood cancer survivor studyStefan S Bielack, Markus Franke
International Orthopaedics|August 10, 2006
Current strategies of chemotherapy in osteosarcomaDorothe Carrle, Stefan S Bielack
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2003
Osteosarcomas occurring as second malignant neoplasmsStefan S Bielack, Marie Dominique Tabone
The New England Journal of Medicine|March 27, 2004
A patient with two Ewing's sarcomas with distinct EWS fusion transcriptsStefan S Bielack, Michael Paulussen, Gabriele Köhler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastasesChristine Franzius, Andreas Schuck, Stefan S Bielack
AJR. American Journal of Roentgenology|April 23, 2010
Indications for CT-guided percutaneous thoracic biopsyStefan S Bielack, Dorothe Carrle, Godehard Friedel
Cancer|June 10, 2011
High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomasStefan S Bielack, Neyssa Marina, Mark Bernstein
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|September 26, 2022
Systemic treatment for primary malignant sarcomas arising in craniofacial bonesStefan S Bielack
European Journal of Cancer (Oxford, England : 1990)|April 14, 2010
Osteosarcoma: time to move on?Stefan S Bielack
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Surgical expertise and outcome in osteosarcoma trialsStefan S Bielack, Heribert Jürgens
Journal of the National Cancer Institute|April 29, 2010
Re: Late recurrence in pediatric cancer: a report from the childhood cancer survivor studyStefan S Bielack, Markus Franke
International Orthopaedics|August 10, 2006
Current strategies of chemotherapy in osteosarcomaDorothe Carrle, Stefan S Bielack
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2003
Osteosarcomas occurring as second malignant neoplasmsStefan S Bielack, Marie Dominique Tabone
The New England Journal of Medicine|March 27, 2004
A patient with two Ewing's sarcomas with distinct EWS fusion transcriptsStefan S Bielack, Michael Paulussen, Gabriele Köhler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastasesChristine Franzius, Andreas Schuck, Stefan S Bielack
AJR. American Journal of Roentgenology|April 23, 2010
Indications for CT-guided percutaneous thoracic biopsyStefan S Bielack, Dorothe Carrle, Godehard Friedel
Cancer|June 10, 2011
High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomasStefan S Bielack, Neyssa Marina, Mark Bernstein
Pageof 10